146 related articles for article (PubMed ID: 21559821)
1. Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer.
Shen XG; Wang C; Li Y; Zhou B; Xu B; Yang L; Zhou ZG; Sun XF
Int J Colorectal Dis; 2011 Dec; 26(12):1519-24. PubMed ID: 21559821
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.
Wang MJ; Li Y; Wang R; Wang C; Yu YY; Yang L; Zhang Y; Zhou B; Zhou ZG; Sun XF
Int J Colorectal Dis; 2013 Feb; 28(2):183-9. PubMed ID: 22885837
[TBL] [Abstract][Full Text] [Related]
3. Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome.
Marchetti A; Barassi F; Martella C; Chella A; Salvatore S; Castrataro A; Mucilli F; Sacco R; Buttitta F
Clin Cancer Res; 2004 Feb; 10(4):1338-43. PubMed ID: 14977834
[TBL] [Abstract][Full Text] [Related]
4. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of caspase-9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome.
Shen XG; Wang C; Li Y; Wang L; Zhou B; Xu B; Jiang X; Zhou ZG; Sun XF
Colorectal Dis; 2010 Dec; 12(12):1213-8. PubMed ID: 19604285
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
7. Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.
Sun X; Sui W; Huang M; Wang Y; Xuan Y; Wang Z
Diagn Pathol; 2014 Nov; 9():217. PubMed ID: 25403684
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
11. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Wang X; Wang J; Ma H; Zhang J; Zhou X
Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
[TBL] [Abstract][Full Text] [Related]
13. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated MYH11 expression correlates with poor prognosis in stage II and III colorectal cancer.
Wang RJ; Wu P; Cai GX; Wang ZM; Xu Y; Peng JJ; Sheng WQ; Lu HF; Cai SJ
Asian Pac J Cancer Prev; 2014; 15(17):7223-8. PubMed ID: 25227818
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
Zhou T; Zhang G; Liu Z; Xia S; Tian H
Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
[TBL] [Abstract][Full Text] [Related]
16. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
19. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
20. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
